≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_PANCREAS_ADENO_DUCTAL_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C25
  • Cancer registry: Morphology ICD-O-3 — 8140|8500
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

1159

4. Check minimum number of events

None

1159

5. Include endpoints

None

1159

6. Filter based on genotype QC (FinnGen only)

1159

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1159 490 669
Unadjusted period prevalence (%) 0.24 0.17 0.29
Median age at first event (years) 70.13 69.87 70.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1063
Matched controls
10630
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
199.6
323.0
444
38
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
323.0
460
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
133.3
323.0
426
53
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
323.0
688
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
141.5
323.0
416
48
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
323.0
581
*
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
763
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1421.6
323.0
372
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
238.0
323.0
392
26
A03FA01
ATC
metoclopramide; systemic, rectal
29.1
323.0
676
602
A04AA02
ATC
granisetron; systemic, transdermal
1718.0
323.0
419
*
Z51.5
ICD-10 Finland
Palliative care
50.6
311.9
377
114
JLC30
NOMESCO Finland
Pancreatoduodenectomy
957.5
302.8
283
*
N02AA05
ATC
oxycodone; systemic
16.5
302.2
557
666
L01BC06
ATC
capecitabine; oral
+∞
290.3
265
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1637.4
269.7
251
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
232.0
214
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
212.8
197
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
205.0
190
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
38.5
195.2
250
84
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
194.9
181
*
UJK02
NOMESCO Finland
ERCP
33.9
188.2
249
95
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
183.7
178.9
183
12
K83.1
ICD-10 Finland
Obstruction of bile duct
83.0
177.3
197
29
8140/3-C25.0
ICD-O-3
Adenocarcinoma, NOS, of head of pancreas
+∞
176.0
164
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
123.4
173.5
184
18
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
53.0
166.4
199
46
JN4BD
NOMESCO Finland
Extensive body CT
15.3
164.5
288
251
A04AA01
ATC
ondansetron; systemic, rectal
34.2
157.9
208
75
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
151.8
142
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
145.2
136
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
21.2
135.6
206
119
JN4AD
NOMESCO Finland
Body CT examination
18.1
132.7
214
146
8500/3-C25.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of pancreas, NOS
+∞
129.9
122
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
42.9
129.1
161
44
JN4CD
NOMESCO Finland
Very extensive body CT
27.3
121.0
169
73
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.2
117.7
478
1453
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
109.3
103
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
578.8
107.7
105
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
55.3
107.1
127
26
JAH01
NOMESCO Finland
Laparoscopy
18.8
105.9
167
104
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
34.5
103.9
136
45
R4190
NOMESCO Finland
Nutritional therapy
27.9
101.8
141
58
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
11.5
101.4
200
210
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
99.5
94
*
L03AA02
ATC
filgrastim; parenteral
117.5
99.0
106
10
TPX10
NOMESCO Finland
Implantation of vascular injection port
23.2
97.1
142
70
WZC30
NOMESCO Finland
Teaching
6.9
95.0
263
481
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
28.7
92.6
127
50
D76
ICPC
Malignant neoplasm pancreas
+∞
92.0
87
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
59.2
87.0
102
19
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
25.1
85.0
121
54
A06AH03
ATC
naloxegol; oral
136.8
83.3
88
7
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
80.2
76
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
79.1
75
*
L03AA13
ATC
pegfilgrastim; parenteral
803.9
77.3
75
*
B01AB10
ATC
tinzaparin; parenteral
9.3
75.3
165
205
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.0
70.4
255
627
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
154.2
68.8
72
5
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
68.5
65
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.6
66.9
167
254
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
+∞
66.3
63
*
8140/3-C25.2
ICD-O-3
Adenocarcinoma, NOS, of tail of pancreas
+∞
66.3
63
*
JDE00
NOMESCO Finland
Gastrojejunostomy
678.0
65.6
64
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.1
64.6
192
371
R50.9
ICD-10 Finland
Fever, unspecified
4.5
64.1
260
711
WW500
NOMESCO Finland
Blood transfusion
14.4
61.2
106
81
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
219.1
60.7
62
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.8
60.1
222
549
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
60.0
57
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
60.0
57
*
B01AB05
ATC
enoxaparin; parenteral
3.1
59.4
434
1910
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
58.9
56
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
10.3
56.0
114
122
JLC10
NOMESCO Finland
Distal pancreatectomy
296.4
55.7
56
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
55.6
53.4
63
12
K83.0
ICD-10 Finland
Cholangitis
18.3
52.9
83
49
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
22.6
52.1
76
36
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
521.6
50.9
50
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
82.8
49.4
55
7
8140/3-C25.1
ICD-O-3
Adenocarcinoma, NOS, of body of pancreas
+∞
49.3
47
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
92.9
48.3
53
6
JMA10
NOMESCO Finland
Transabdominal total splenectomy
64.3
47.7
55
9
A04AD12
ATC
aprepitant; systemic
488.6
47.7
47
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
170.9
47.2
49
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
47.2
45
*
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
466.7
45.6
45
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.6
44.4
169
422
JAH00
NOMESCO Finland
Laparotomy
10.4
43.4
87
90
R18
ICD-10 Finland
Ascites
16.1
43.3
71
47
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
41.4
302
1268
191
Kela drug reimbursment
Erlotinib
+∞
40.9
39
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.7
40.0
145
343
A98
ICPC
Health maint/preventive medicine
0.4
39.3
637
8381
C61
ICD-10 Finland
Malignant neoplasm of prostate
207.5
39.1
40
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
38.8
37
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
38.0
212
731
XX3DW
NOMESCO Finland
Time consuming IT work
5.7
37.8
115
223
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
37.7
36
*
J01MA12
ATC
levofloxacin; systemic
2.9
37.7
276
1150
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
37.2
178
543
WF002
NOMESCO Finland
Radical radiotherapy
85.2
37.1
41
5
A02BC02
ATC
pantoprazole; systemic
2.3
34.8
728
5169
A79
ICPC
Malignancy NOS
+∞
34.6
33
*
1CD01
NOMESCO Finland
NA
+∞
34.6
33
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
17.4
33.5
53
32
ZX120
NOMESCO Finland
Intravenous
4.0
33.3
142
390
N02AX02
ATC
tramadol; systemic, rectal
2.2
33.1
508
3097
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.3
32.7
104
212
A10AE04
ATC
insulin glargine; parenteral
3.4
32.6
177
592
L01XE03
ATC
[U] erlotinib; oral
+∞
32.5
31
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
31.4
30
*
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
34.6
31.1
40
12
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
321.8
31.0
31
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.6
30.7
68
84
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
30.3
29
*
A06AD11
ATC
lactulose; oral
2.7
29.9
242
1051
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
109.8
29.8
32
*
115
Kela drug reimbursment
Breast cancer
+∞
29.3
28
*
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
10.0
29.2
59
62
WX402
NOMESCO Finland
General anaesthesia
3.1
28.1
173
632
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.7
27.9
214
897
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
36.1
27.6
35
10
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.1
27.3
58
67
WF004
NOMESCO Finland
Palliative radiotherapy
277.6
26.8
27
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
18.8
26.3
40
22
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
37.8
26.3
33
9
N02AA01
ATC
morphine; systemic, rectal
20.2
26.2
39
20
1570A
ICD-9 Finland
Malignant neoplasm of pancreas, Head of pancreas
+∞
26.1
25
*
WX004
NOMESCO Finland
Patient-controlled sedation
30.9
25.1
33
11
116
Kela drug reimbursment
Prostate cancer
+∞
25.1
24
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
25.1
236
1104
SPAT1109
SPAT
Analgesia with portable analgesic pump
24.1
24.9
35
15
ZX122
NOMESCO Finland
Intra-arterial
25.0
24.5
34
14
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
24.4
371
2169
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
24.3
278
1434
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
21.9
23.5
34
16
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
29.0
23.2
31
11
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
+∞
23.0
22
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.9
22.9
77
167
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
85.3
22.7
25
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
85.3
22.7
25
*
N05BA06
ATC
lorazepam; systemic, sublingual
4.0
22.7
96
260
PJA12
NOMESCO Finland
Sentinel node biopsy
234.7
22.7
23
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
21.9
22.2
32
15
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
21.9
21
*
TJA10
NOMESCO Finland
Laparocentesis
+∞
21.9
21
*
K85.8
ICD-10 Finland
Other acute pancreatitis
22.8
21.8
31
14
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
224.3
21.7
22
*
JLA00
NOMESCO Finland
Exploration of pancreas
+∞
20.9
20
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.7
20.4
91
259
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
58.7
20.0
23
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
19.8
19
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
19.8
19
*
B01AB04
ATC
dalteparin; parenteral
3.9
19.8
85
234
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.1
19.2
38
39
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
23.0
19.1
27
12
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
10.3
19.0
37
37
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
18.8
18
*
JLA10
NOMESCO Finland
Biopsy of pancreas
+∞
18.8
18
*
K86.1
ICD-10 Finland
Other chronic pancreatitis
12.6
18.2
32
26
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
17.8
17
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
182.8
17.6
18
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.5
17.3
123
2375
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
64.4
16.8
19
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
35.6
16.7
21
6
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
91.5
16.6
18
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
91.5
16.6
18
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
172.5
16.5
17
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.2
16.3
44
74
N05AD01
ATC
haloperidol; systemic
4.2
16.3
63
158
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.2
16.0
61
151
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
15.8
354
2306
ZX121
NOMESCO Finland
Central venous catheter
60.9
15.8
18
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
15.7
328
2088
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
15.7
15
*
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
15.7
15
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
162.2
15.5
16
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
162.2
15.5
16
*
A41.8
ICD-10 Finland
Other specified sepsis
6.1
15.2
41
69
N06DX01
ATC
memantine; oral
0.1
15.1
7
561
WX002
NOMESCO Finland
Sedation and analgesia
2.0
14.9
233
1333
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.5
14.8
101
1994
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
+∞
14.6
14
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
14.2
139
652
J94.8
ICD-10 Finland
Other specified pleural conditions
6.8
14.1
35
53
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
13.9
179
948
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.5
13.9
130
2317
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.4
13.9
50
118
WF003
NOMESCO Finland
Adjuvant radiotherapy
54.0
13.8
16
*
C10AA05
ATC
atorvastatin; oral
0.6
13.8
225
3431
C10AA07
ATC
rosuvastatin; oral
0.5
13.7
96
1879
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.7
13.6
59
165
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
13.6
13
*
JFA65
NOMESCO Finland
Endoscopic insertion of ileum stent
+∞
13.6
13
*
TPX15
NOMESCO Finland
Removal of vascular injection port
26.1
13.4
18
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
13.3
461
3374
P20
ICPC
Memory disturbance
0.3
13.2
38
1054
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
6.0
12.9
35
60
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.1
12.9
8
527
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
5.1
12.7
39
78
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.6
12.6
189
2961
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
12.5
12
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
12.5
12
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
12.5
12
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
12.5
12
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
12.5
12
*
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
24.6
12.5
17
7
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
131.4
12.5
13
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
38.0
12.2
15
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
27.0
12.1
16
6
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
27.0
12.1
16
6
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
47.2
11.9
14
*
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
11.9
359
4783
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.2
11.9
28
40
M25.5
ICD-10 Finland
Pain in joint
0.5
11.6
87
1673
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
11.6
39
1011
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
10.2
11.5
22
22
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
11.5
11
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
11.5
11
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
11.5
11
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
11.5
11
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
11.5
11
*
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
11.5
11
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
11.5
11
*
L02BA01
ATC
tamoxifen; oral
+∞
11.5
11
*
V03AF03
ATC
calcium folinate; systemic
121.2
11.4
12
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
11.4
91
384
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
11.4
124
2129
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
35.4
11.3
14
*
H25.1
ICD-10 Finland
Senile nuclear cataract
0.6
11.2
152
2456
WX610
NOMESCO Finland
Patient controlled analgesia
25.3
11.2
15
6
WX892
NOMESCO Finland
Monitored bed care
2.4
11.1
98
436
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
11.1
219
3224
SPAT1053
SPAT
Memory test
0.4
10.9
65
1358
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.5
10.8
37
84
C10AX09
ATC
ezetimibe; oral
0.3
10.6
28
808
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
60.6
10.6
12
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.4
10.6
31
59
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
10.6
53
1173
A21
ICPC
Risk factor for malignancy
111.0
10.4
11
*
JDE01
NOMESCO Finland
Laparoscopic gastroenterostomy
111.0
10.4
11
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.4
10
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
10.4
10
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
10.4
10
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
JDH35
NOMESCO Finland
Endoscopic insertion of duodenal stent
+∞
10.4
10
*
325
Kela drug reimbursment
Erlotinib
+∞
10.4
10
*
L02BB03
ATC
bicalutamide; oral
+∞
10.4
10
*
JKD00
NOMESCO Finland
Anastomosis of gallbladder to jejunum
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
+∞
10.4
10
*
L02BG04
ATC
letrozole; oral
32.8
10.3
13
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.4
10.3
48
144
WX600
NOMESCO Finland
Single shot through catheter
19.0
10.3
15
8
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
11.4
10.1
18
16
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
8.5
10.1
21
25
I50.9
ICD-10 Finland
Heart failure, unspecified
0.5
10.0
69
1368
L02AE02
ATC
leuprorelin; implant, parenteral
20.2
9.8
14
7
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
9.7
304
4075
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.9
9.6
21
27
WX320
NOMESCO Finland
Spinalanesthesy
0.5
9.6
89
1610
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.3
9.6
28
54
WX882
NOMESCO Finland
High dependency care
3.7
9.5
40
111
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
9.4
56
200
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
100.9
9.4
10
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
30.3
9.4
12
*
KA1FN
NOMESCO Finland
Isotope renography
30.3
9.4
12
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
9.4
9
*
PHN72
NOMESCO Finland
Plastic repair of superior mesenteric or portal vein
+∞
9.4
9
*
D13
ICPC
Jaundice
+∞
9.4
9
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
9.4
9
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
6706
FHL
Pancreatic homeectomy (eg Whipple)
+∞
9.4
9
*
F03
ICD-10 Finland
Unspecified dementia
0.1
9.3
5
364
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.6
9.3
141
2231
R83
ICPC
Respiratory infection other
0.4
9.3
37
900
K86.3
ICD-10 Finland
Pseudocyst of pancreas
10.8
9.3
17
16
Z01.2
ICD-10 Finland
Dental examination
0.6
9.3
152
2362
JKA20
NOMESCO Finland
Cholecystectomy
3.3
9.2
45
141
M79.6
ICD-10 Finland
Pain in limb
0.6
9.2
152
2356
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
10.1
9.0
17
17
K31.5
ICD-10 Finland
Obstruction of duodenum
37.0
9.0
11
*
WX704
NOMESCO Finland
Intubation
2.5
9.0
70
291
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.5
8.9
30
68
I81
ICD-10 Finland
Portal vein thrombosis
10.8
8.8
16
15
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
10.8
8.8
16
15
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.0
8.8
23
39
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.6
8.7
128
2047
K02.1
ICD-10 Finland
Caries of dentine
0.6
8.7
257
3512
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
8.6
133
2097
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.4
8.5
41
928
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
8.5
47
1011
R11
ICD-10 Finland
Nausea and vomiting
2.2
8.5
86
409
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.5
8.5
65
270
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
27.7
8.5
11
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
20.2
8.5
12
6
G04BD12
ATC
mirabegron; oral
0.3
8.5
23
655
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
8.4
137
786
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.6
8.4
162
2427
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
8.3
8
*
8500/3-C25.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of body of pancreas
+∞
8.3
8
*
1571A
ICD-9 Finland
Malignant neoplasm of pancreas, Body of pancreas
+∞
8.3
8
*
PHC71
NOMESCO Finland
Suture of mesenteric or portal vein
+∞
8.3
8
*
R5140
NOMESCO Finland
Monitoring the use of the aid
0.3
8.3
21
622
K86.8
ICD-10 Finland
Other specified diseases of pancreas
10.8
8.3
15
14
L03
ICPC
Low back symptom/complaint
0.5
8.3
84
1485
B01AC04
ATC
clopidogrel; oral
0.5
8.2
79
1418
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.7
8.1
272
3633
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
33.6
8.1
10
*
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
33.6
8.1
10
*
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
17.3
8.1
12
7
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
8.1
58
231
C10AC01
ATC
colestyramine; oral
3.4
8.0
37
112
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.3
7.9
13
477
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.3
7.8
20
588
R4110
NOMESCO Finland
Physiotherapy
1.6
7.8
240
1660
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.9
7.7
45
161
207
Kela drug reimbursment
Chronic arrhythmias
0.5
7.6
66
1224
HAB40
NOMESCO Finland
Wedge excision of mammary gland
11.9
7.6
13
11
R03AC02
ATC
salbutamol; inhalant
0.7
7.6
287
3760
SPAT1262
SPAT
Handing over of treatment supplies
1.6
7.6
200
1329
L13
ICPC
Hip symptom/complaint
0.5
7.5
58
1117
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
7.5
45
164
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.6
7.5
150
2237
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
7.5
466
5603
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
80.6
7.4
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
80.6
7.4
8
*
E14.8
ICD-10 Finland
Unspecified diabetes mellitus, with unspecified complications
13.5
7.4
12
9
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.6
7.4
91
1526
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
8500/3-C25.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of tail of pancreas
+∞
7.3
7
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
Y77
ICPC
Malignant neoplasm prostate
+∞
7.3
7
*
L01BC04
ATC
carmofur; oral
+∞
7.3
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
7.3
7
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
7.3
7
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
C25.3
ICD-10 Finland
Malignant neoplasm: Pancreatic duct
+∞
7.3
7
*
L15
ICPC
Knee symptom/complaint
0.5
7.2
75
1323
N06DA03
ATC
rivastigmine; oral, transdermal
0.2
7.2
5
304
HA1AA
NOMESCO Finland
X-ray mammography
3.7
7.2
29
79
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
20.2
7.1
10
5
N02AA03
ATC
hydromorphone; systemic, rectal
20.2
7.1
10
5
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.4
7.1
59
256
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.5
7.1
41
869
N05BA04
ATC
oxazepam; oral
1.6
7.1
230
1602
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
7.0
11
409
M70.6
ICD-10 Finland
Trochanteric bursitis
0.4
7.0
34
767
WX725
NOMESCO Finland
Noninvasive ventilation
2.6
7.0
49
196
M48.0
ICD-10 Finland
Spinal stenosis
0.5
6.9
48
949
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.7
6.8
219
2973
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
6.8
271
1979
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
6.1
6.8
17
28
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.5
6.8
46
919
XF612
NOMESCO Finland
Measurement of central venous pressure
16.8
6.7
10
6
AA1AD
NOMESCO Finland
CT of head and brain
0.6
6.7
127
1923
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
6.7
131
1968
R05
ICPC
Cough
0.6
6.7
81
1367
JFC00
NOMESCO Finland
Entero-enterostomy
22.7
6.7
9
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.4
6.7
56
245
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.6
6.6
82
1378
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
6.5
6.6
16
25
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.6
6.6
28
80
SPAT1255
SPAT
Intravenous administration of medicine
2.1
6.6
69
337
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.7
6.6
42
157
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
6.6
202
2770
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
0.4
6.6
35
761
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.7
6.6
252
3313
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.4
6.6
31
706
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
10.1
6.5
12
12
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.4
6.5
25
616
D70.89
ICD-10 Finland
Neutropenic splenomegaly
6.9
6.5
15
22
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.0
6.5
*
165
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.0
6.5
35
120
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
3.9
6.5
25
66
N05AX08
ATC
risperidone; systemic
0.4
6.5
19
523
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
70.2
6.4
7
*
K75.0
ICD-10 Finland
Abscess of liver
14.4
6.4
10
7
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
6.0
6.3
16
27
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
11.1
6.3
11
10
B01AF02
ATC
apixaban; oral
0.4
6.3
33
719
R93.3
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of digestive tract
18.1
6.3
9
5
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
6.3
6
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
1579X
ICD-9 Finland
Malignant neoplasm of pancreas, Pancreas, part unspecified
+∞
6.3
6
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
6.3
6
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
NK6LA
NOMESCO Finland
Bone and joint kinetic X-ray examination
+∞
6.3
6
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
6.3
6
*
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.2
374
2950
RD210
NOMESCO Finland
NA
4.8
6.2
19
40
A10AE05
ATC
insulin detemir; parenteral
2.2
6.2
61
288
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
26.8
6.2
8
*
H26.4
ICD-10 Finland
After-cataract
0.4
6.2
31
690
CJB10
NOMESCO Finland
Laser discission of secondary cataract
0.4
6.2
26
618
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
6.1
249
1821
DFF00
NOMESCO Finland
Pure tone audiometry
0.4
6.1
21
542
SDA02
NOMESCO Finland
Parodonthologic therapy
0.6
6.1
129
1908
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
12.6
6.1
10
8
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.6
6.0
143
2068

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
311
104
40.50
307.65
8.6
1.6
u/ml
5767.6
55.0
3.30
296
95
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
665
496
30.11
307.65
7.9
1.4
ug/l
107.9
3.6
1.59
640
376
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
428
178
37.54
307.65
8.7
1.8
u/ml
26753.4
164.2
1.17
396
142
(3000570) Elastase.pancreatic [Mass/mass] in Stool
360
227
22.55
307.65
1.6
1.4
ug/g
134.5
294.9
18.62
186
131
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
140
38
41.77
229.27
1.2
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
374
703
7.38
203.97
4.1
1.9
g/l
0.2
0.2
3.12
357
636
(4035726)
208
231
10.76
175.65
1.2
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
385
856
6.24
174.68
6.3
2.4
umol/l
38.1
9.0
15.89
360
742
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
646
2752
4.04
120.91
6.4
2.2
u/l
46.6
59.2
6.45
617
2490
(40768441) Liver Pathology biopsy report
79
32
26.42
113.20
1.1
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
267
717
4.54
92.11
9.1
2.1
u/l
175.3
35.4
0.61
247
588
(3023368) Bacteria identified in Blood by Culture
568
2561
3.39
90.56
7.6
4.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
603
8913
0.33
75.87
3.6
5.5
mmol/l
2.6
2.6
0.23
509
8067
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
564
8590
0.33
74.30
3.4
4.8
mmol/l
1.4
1.4
3.62
471
7757
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
576
8674
0.33
73.72
3.4
4.9
mmol/l
4.4
4.5
0.56
483
7895
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
740
4293
3.00
69.92
29.6
3.8
umol/l
20.8
12.3
7.03
723
3996
(3024561) Albumin [Mass/volume] in Serum or Plasma
675
3855
2.80
63.41
15.1
3.6
g/l
30.5
35.1
67.59
657
3535
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
558
8302
0.37
60.61
3.2
4.3
mmol/l
1.3
1.3
0.95
468
7424
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
498
2511
2.72
58.64
7.9
2.6
u/l
62.2
36.7
7.24
481
2376
(3012095) Magnesium [Moles/volume] in Serum or Plasma
325
1314
3.05
57.97
3.4
2.6
mmol/l
0.8
0.8
2.34
309
1201
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
627
8765
0.38
55.72
4.0
5.1
mmol/l
6.9
6.1
14.64
553
7829
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
545
8019
0.40
52.04
3.4
4.7
mu/l
2.1
2.2
0.22
454
7158
(3032080) INR in Blood by Coagulation assay
654
3940
2.51
51.02
11.1
11.2
inr
1.2
1.4
4.46
174
1062
(3042936) Bacteria identified in Isolate by Culture
301
1266
2.86
49.02
2.2
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
465
2492
2.45
45.55
3.5
2.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
624
8465
0.43
42.23
7.0
6.6
mmol/mol
45.3
41.0
13.38
571
7739
(3033658) Prothrombin time (PT) actual/Normal
396
2047
2.42
41.24
7.7
3.6
%
76.6
83.6
7.61
389
1984
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
418
6590
0.43
41.01
3.0
3.8
pmol/l
15.0
15.0
0.21
350
5853
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
354
1744
2.48
40.95
11.4
2.2
mmol/l
2.5
2.4
10.16
344
1490
(3000963) Hemoglobin [Mass/volume] in Blood
769
9554
0.42
39.41
59.8
21.0
g/l
116.5
135.0
186.75
747
9329
(3026361) Erythrocytes [#/volume] in Blood
769
9552
0.42
39.30
59.4
20.9
e12/l
3.9
4.5
122.72
739
9155
(3010813) Leukocytes [#/volume] in Blood
769
9552
0.42
39.30
59.4
20.9
e9/l
7.8
6.8
17.00
738
9162
(3035941) MCH [Entitic mass]
769
9551
0.42
39.25
59.2
20.8
pg
30.1
30.5
7.99
750
9330
(3024731) MCV [Entitic volume]
769
9551
0.42
39.25
59.3
20.9
fl
91.4
91.6
0.80
750
9330
(3007461) Platelets [#/volume] in Blood
769
9549
0.42
39.14
59.4
20.9
e9/l
260.0
240.8
7.82
744
9205
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
46
49
9.73
39.09
1.6
1.3
ug/l
16.5
15.8
0.11
46
49
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
172
624
3.06
35.80
1.6
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
62
106
6.12
35.07
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
110
305
3.88
34.91
2.6
2.7
u/ml
0.3
0.4
2.38
63
180
(3013650) Neutrophils [#/volume] in Blood by Automated count
674
4583
2.12
33.73
30.3
6.1
e9/l
4.5
4.4
0.40
630
3905
(3002256) Pathology report gross observation
159
589
2.97
31.74
1.6
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
476
2891
2.10
31.61
11.4
2.1
mmol/l
2.3
2.4
9.29
453
2346
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
576
3764
2.05
31.23
6.1
3.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
623
8133
0.49
29.67
42.9
13.3
ml/min/173m2
83.6
73.6
27.80
563
6545
(40768804) Tissue Pathology biopsy report
427
2547
2.07
29.25
2.8
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
765
9307
0.48
29.16
45.4
17.6
mmol/l
3.9
4.0
6.99
743
9006
(3019550) Sodium [Moles/volume] in Serum or Plasma
765
9287
0.48
28.33
45.7
17.5
mmol/l
137.5
139.7
62.51
743
9000
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
761
9248
0.48
28.05
33.1
9.4
u/l
43.3
25.2
31.26
740
8790
(3024980) IgG subclass 4 [Mass/volume] in Serum
56
110
5.30
27.33
1.3
1.6
g/l
0.9
1.0
0.27
35
86
(3023183) Ammonium ion [Moles/volume] in Plasma
73
184
4.17
26.33
2.0
2.7
umol/l
42.1
33.4
1.38
52
159
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
338
1939
2.05
25.05
3.3
2.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
234
1183
2.23
23.97
2.8
4.7
mmol/l
1.0
1.0
1.03
219
1076
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
109
398
2.92
22.12
2.1
1.7
ug/l
2.2
1.8
0.12
102
342
(40761511) CBC panel - Blood by Automated count
745
8909
0.54
20.65
36.5
14.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
110
2459
0.39
20.47
1.5
1.7
mmol/l
1.4
1.3
0.20
98
2021
(3023487) Leukocytes [#/volume] in Peritoneal fluid
24
26
9.40
20.03
1.2
2.3
e6/l
18638.5
342.6
0.54
17
19
(3013707) Erythrocyte sedimentation rate by Westergren method
497
6562
0.58
18.40
3.0
4.2
mm/h
19.2
13.2
9.98
449
5982
(3012501) Base excess in Blood by calculation
63
187
3.51
18.01
4.7
4.9
mmol/l
2.9
2.8
0.12
51
127
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
47
114
4.25
17.83
5.9
6.7
mg/l
12.0
12.1
0.03
42
101
(3027315) Oxygen [Partial pressure] in Blood
63
190
3.45
17.58
4.7
4.9
kpa
9.7
8.2
3.76
63
185
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
72
237
3.17
17.46
2.2
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
311
1927
1.84
17.36
23.6
4.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
115
490
2.50
17.18
5.2
7.7
mmol/l
25.0
24.9
0.07
115
485
(3003694) ABO and Rh group [Type] in Blood
314
1988
1.79
16.16
1.4
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
16
13
12.47
16.05
1.1
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
264
1598
1.84
15.69
1.9
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
157
805
2.10
15.09
2.7
6.1
mmol/l
8.0
10.9
5.36
145
757
(3018418) pH of Serum or Plasma
388
2654
1.69
14.97
5.7
3.3
ph
7.4
7.4
0.38
99
430
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
186
3117
0.52
14.91
1.9
2.2
u/l
156.9
237.0
1.12
170
2911
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
557
4186
1.64
14.86
7.6
5.1
mmol/l
1.2
1.2
7.36
530
3688
(3003338) MCHC [Mass/volume]
568
7068
0.61
14.55
55.2
19.1
g/l
328.5
331.9
16.13
561
6993
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
18
21
8.69
14.16
1.2
2.5
e6/l
34130.6
94873.6
—
10
11
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
199
1138
1.90
14.00
1.8
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
170
924
1.98
13.88
8.5
7.2
g/l
113.9
121.2
5.77
162
893
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
192
3110
0.54
13.44
3.8
3.8
%
20.9
24.2
2.25
86
1536
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
197
1139
1.88
13.36
1.9
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
107
499
2.26
13.01
9.8
9.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
147
2561
0.51
12.97
2.9
3.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
118
574
2.18
12.94
1.9
1.5
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
62
224
2.87
12.82
10.2
6.5
mmol/l
105.6
105.5
0.06
55
208
(3039000) Anion gap in Blood
62
224
2.87
12.82
10.2
6.5
mmol/l
10.8
11.1
0.50
55
208
(3033799) Differential panel - Peritoneal fluid
17
21
8.20
12.78
1.1
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
259
3823
0.58
12.76
3.5
4.0
ug/l
2.8
2.2
0.72
206
3386
(3013826) Glucose [Moles/volume] in Serum or Plasma
671
5394
1.58
12.70
8.2
4.5
mmol/l
8.0
6.9
20.12
651
5052
(3003434) Protein [Mass/volume] in Pleural fluid
41
116
3.63
12.63
1.1
1.4
g/l
36.1
27.3
1.97
36
102
(3026782) Osmolality of Urine
274
1780
1.71
12.45
2.9
2.6
mosm/kgh2o
538.4
549.0
0.32
247
1483
(3044007) Cell count panel - Peritoneal fluid
16
19
8.52
12.39
1.1
2.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
203
1212
1.82
12.36
1.8
2.5
%
18.8
22.5
2.74
175
1012
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
585
4583
1.56
12.21
8.0
5.5
mmol/l
1.2
1.2
5.39
472
3872
(3009542) Hematocrit [Volume Fraction] of Blood
626
7500
0.64
12.19
42.7
16.0
%
34.3
39.0
20.57
370
4647
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
292
4132
0.61
11.90
2.5
2.3
—
—
—
0
0
(4281824)
23
43
5.44
11.85
1.1
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
175
1012
1.86
11.78
8.3
6.8
%
96.9
94.9
8.32
167
979
(3023199) Leukocytes [#/volume] in Pleural fluid
38
108
3.60
11.64
1.2
1.5
e6/l
2718.1
1719.8
0.37
30
76
(4062490)
29
68
4.35
11.52
1.2
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
304
4238
0.62
11.51
2.1
2.1
pmol/l
94.3
93.6
0.09
197
2146
(3028192) IgG subclass 2 [Mass/volume] in Serum
29
69
4.29
11.32
1.1
1.2
g/l
3.5
2.9
1.18
14
51
(3024139) IgG subclass 3 [Mass/volume] in Serum
29
69
4.29
11.32
1.1
1.2
g/l
0.6
0.4
0.83
14
50
(3027135) IgG subclass 1 [Mass/volume] in Serum
29
69
4.29
11.32
1.1
1.2
g/l
6.4
7.4
0.53
14
51
(3002582) Erythrocytes [#/volume] in Urine
376
2701
1.58
11.27
3.3
3.1
e6/l
25.6
88.0
1.79
311
2071
(3026493) Urate [Moles/volume] in Serum or Plasma
144
2418
0.54
10.97
2.3
2.5
umol/l
339.8
8045.8
9.80
112
2029
(3004789) Transferrin [Mass/volume] in Serum or Plasma
209
1303
1.74
10.89
1.8
2.4
g/l
2.2
2.3
1.56
204
1198
(3028308) Erythrocytes [#/volume] in Pleural fluid
35
100
3.58
10.65
1.2
1.6
e6/l
36356.0
97580.1
0.43
22
55
(3047181) Lactate [Moles/volume] in Blood
73
316
2.40
10.54
9.5
5.9
mmol/l
1.5
1.3
1.47
63
286
(3008152) Bicarbonate [Moles/volume] in Arterial blood
124
665
1.97
10.44
10.7
6.8
mmol/l
24.5
24.6
0.23
115
624
(3019060) Gas panel - Arterial blood
127
688
1.95
10.39
7.8
4.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
1294
0.41
10.20
1.1
1.2
u/ml
19.3
13.7
0.14
17
461
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
118
3.30
10.19
1.2
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
183
1126
1.74
9.94
8.1
6.6
mmol/l
1.2
1.3
0.23
156
877
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
62
1346
0.43
9.92
1.1
1.3
iu/ml
63.0
41.3
0.43
14
416
(3012516) Albumin [Mass/volume] in Urine
217
3192
0.61
9.90
2.6
3.3
mg/l
143.5
216.0
0.42
132
2022
(3030467) Casts [#/volume] in Urine by Automated count
342
2468
1.55
9.79
3.3
3.0
e6/l
0.6
0.4
1.07
282
1865
(3045788) Cell count panel - Pleural fluid
32
92
3.55
9.67
1.2
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
126
2130
0.54
9.65
2.5
2.8
ug/l
0.6
0.8
1.44
82
1492
(3027801) Oxygen [Partial pressure] in Arterial blood
182
1131
1.72
9.52
8.1
6.6
kpa
14.0
11.4
8.02
172
1084
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
182
1131
1.72
9.52
8.1
6.6
kpa
5.0
5.1
0.66
173
1086
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
764
8635
0.66
9.52
44.0
14.3
mg/l
41.0
25.4
24.93
741
6813
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
47
173
2.79
9.44
1.2
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
45
163
2.83
9.31
1.2
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
33
101
3.33
9.08
1.2
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
537
6465
0.68
9.06
4.3
4.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
14
9
15.72
9.04
1.4
1.1
u/ml
267.8
18.4
—
14
9
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
46
172
2.74
8.98
1.9
2.1
%
230.5
199.5
1.50
40
161
(3020891) Body temperature
86
428
2.09
8.90
6.9
4.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
229
3247
0.63
8.66
2.5
3.2
mmol/l
7.0
7.3
0.71
184
2700
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
37
4.93
8.38
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
64
294
2.25
8.11
1.3
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
322
2373
1.49
8.11
3.3
3.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
239
3310
0.65
7.96
2.1
3.1
ng/l
1415.2
1662.4
0.39
214
2847
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
47
4.31
7.96
1.3
1.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
118
682
1.81
7.89
7.1
3.1
mmol/l
1.2
1.2
0.63
108
567
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
80
3.43
7.83
1.3
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
134
809
1.74
7.73
4.5
6.0
mmol/l
1.6
1.4
0.42
129
772
(3020682) Albumin/Creatinine [Ratio] in Urine
247
3378
0.66
7.68
3.3
4.0
mg/mmol
21.1
7.8
1.45
144
2138
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
29
92
3.21
7.57
1.1
1.2
nmol/l
1.1
1.5
1.05
23
81
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
36
130
2.83
7.54
1.1
1.1
iu/ml
44.4
71.8
—
5
26
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
143
2.71
7.37
4.0
3.1
%
60.9
59.1
0.44
38
143
(3002385) Erythrocyte distribution width [Ratio]
594
6904
0.71
7.31
53.3
17.2
%
15.3
13.8
72.97
582
6701
(40768806) Pleura Pathology biopsy report
25
74
3.43
7.27
1.3
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
128
777
1.73
7.24
5.1
7.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
65
1238
0.50
7.14
3.4
5.1
%
33.5
33.3
0.04
40
801
(3021447) Carbon dioxide [Partial pressure] in Venous blood
149
946
1.66
7.13
3.0
3.1
kpa
5.6
5.9
2.58
143
911
(3002032) Base excess in Venous blood by calculation
148
941
1.66
7.05
3.1
3.1
mmol/l
1.9
2.1
0.25
121
757
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
61
3.66
7.04
1.3
1.6
—
—
—
0
0
(3012544) pH of Venous blood
153
985
1.64
6.93
3.2
3.1
—
7.4
—
0
6
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
411
3251
1.41
6.90
3.5
3.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
14
7.20
6.70
1.0
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
21
5.76
6.59
1.2
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
145
933
1.63
6.58
6.7
3.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
359
2795
1.41
6.52
4.2
5.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
277
3618
0.69
6.52
2.2
2.2
nmol/l
66.1
79.0
11.63
254
3119
(3007930) Methemoglobin/Hemoglobin.total in Blood
77
413
1.93
6.52
9.2
4.7
%
1.0
0.9
1.78
69
396
(3000850) Epithelial cells [#/volume] in Urine
259
1900
1.47
6.50
2.5
2.4
e6/l
7.0
5.0
0.92
235
1649
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
77
421
1.89
6.16
9.2
4.6
%
1.8
1.7
0.29
69
404
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
15
35
4.33
6.03
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
15
35
4.33
6.03
1.1
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
44
3.91
6.00
7.7
4.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
28
102
2.79
5.82
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
20
5.54
5.81
1.1
2.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
109
675
1.68
5.74
3.4
4.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
34
139
2.49
5.65
3.3
2.9
e9/l
4.4
4.5
0.04
34
139
(3024354) Oxygen [Partial pressure] in Venous blood
122
783
1.62
5.60
2.8
2.5
kpa
4.6
4.5
0.14
116
748
(3035880) pH of Pleural fluid
16
42
3.85
5.55
1.1
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
751
6694
1.35
5.39
31.1
5.3
u/l
189.7
77.0
48.25
733
6125
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
42
194
2.21
5.34
1.2
1.5
nmol/l
0.6
0.8
1.51
36
157
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
78
451
1.78
5.26
2.4
3.5
mmol/l
24.4
24.3
0.06
73
397
(3004588) Protein electrophoresis panel - Serum or Plasma
31
686
0.44
5.18
1.9
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
385
3128
1.35
5.15
3.7
3.6
e6/l
71.9
116.0
1.05
313
2230
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
37
762
0.47
5.10
2.9
3.5
ng/l
121.4
91.8
0.89
30
657
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
29
116
2.54
5.07
1.3
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
24
89
2.73
4.86
1.2
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
131
2.40
4.84
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
83
1315
0.60
4.76
17.5
7.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
185
2476
0.70
4.72
1.6
1.6
nmol/l
21.5
20.5
0.46
173
2065
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
104
2.53
4.57
1.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
385
0.30
4.54
1.4
1.9
—
—
—
0
0
(4094501)
6
243
0.24
4.52
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
105
2.51
4.48
1.3
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
40
197
2.07
4.37
1.1
1.1
titre
114.0
88.6
—
5
14
(3017143) Hepatitis C virus Ab [Presence] in Serum
91
579
1.62
4.36
1.2
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
94
603
1.61
4.35
1.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
43
793
0.52
4.28
1.3
1.4
—
—
—
0
0
(3036489) Thrombin time
49
262
1.91
4.27
1.8
1.8
s
24.9
21.4
1.52
44
233
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
191
1425
1.41
4.27
3.3
2.8
e6/l
3.1
2.2
0.41
110
773
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
430
0.36
4.26
1.3
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
458
3899
1.29
4.18
4.1
5.7
%
20.5
26.6
21.40
429
3565
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
580
5092
1.28
4.12
5.7
3.0
u/l
254.1
51.4
24.56
550
4602
(3019069) Monocytes/100 leukocytes in Blood
451
3841
1.29
4.07
4.1
5.9
%
8.5
8.9
1.16
426
3531
(3016650) Hepatitis A virus Ab [Presence] in Serum
25
104
2.43
4.07
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
219
1.95
3.96
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
219
1.95
3.96
1.5
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
26
112
2.35
3.94
1.9
2.0
%
89.7
89.8
0.06
26
112
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
43
3.28
3.91
1.2
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
43
3.28
3.91
1.2
1.5
—
—
—
0
0
(1002224) Polysomnography panel
7
241
0.29
3.90
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
16
54
2.99
3.86
1.1
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
159
2.11
3.85
1.3
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
165
2171
0.72
3.72
3.8
3.7
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
56
2.88
3.63
1.1
1.1
mmol/l
12.8
12.4
—
9
21
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
231
0.30
3.62
1.1
1.2
—
45.2
—
0
13
(3019150) Specific gravity of Urine by Refractometry
154
2040
0.72
3.61
4.0
4.1
kg/l
1.0
1.0
0.18
29
315
(3006504) Eosinophils/100 leukocytes in Blood
444
3823
1.26
3.55
4.1
5.6
%
2.3
3.0
6.99
420
3502
(3000492) Spirometry study
37
672
0.54
3.54
1.2
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
52
2.91
3.47
1.2
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
359
0.38
3.41
1.1
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
224
0.31
3.34
1.1
1.2
—
3.7
—
0
40
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
128
2.14
3.31
3.7
2.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
220
0.31
3.20
1.1
1.2
—
3.0
—
0
22
(40767503) Oxygen content in Capillary blood by calculation
35
187
1.90
3.13
2.1
2.6
%
13.4
16.3
—
10
98
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
425
0.46
3.09
1.0
1.2
iu/ml
269.9
128.7
—
8
157
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
54
846
0.62
2.99
1.4
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
63
405
1.59
2.97
1.1
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
57
877
0.63
2.92
1.3
1.3
—
—
—
0
0
(44790047)
19
82
2.34
2.92
1.1
1.5
—
—
—
0
0
(44790049)
19
82
2.34
2.92
1.1
1.5
—
—
—
0
0
(44790048)
19
82
2.34
2.92
1.1
1.5
—
—
—
0
0
(44806118)
19
82
2.34
2.92
1.1
1.5
—
—
—
0
0
(4010399)
42
691
0.59
2.85
1.1
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
91
640
1.46
2.84
2.4
3.9
%
1.1
0.8
0.61
58
141
(3022096) Basophils/100 leukocytes in Blood
425
3712
1.23
2.84
4.1
5.6
%
0.6
0.7
4.63
401
3407
(3044941) Cell count panel - Synovial fluid
5
175
0.28
2.83
1.2
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
68
999
0.66
2.82
1.1
1.3
titre
435.6
604.1
—
9
244
(3018010) Neutrophils/100 leukocytes in Blood
440
3862
1.22
2.79
3.9
5.6
%
63.1
58.2
10.04
414
3554
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
33
181
1.85
2.76
1.4
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
21
98
2.16
2.72
1.0
1.3
u/ml
111.4
112.6
—
5
15
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
184
0.32
2.68
1.2
1.2
—
8.6
—
0
14
(40760892) CBC W Ordered Manual Differential panel - Blood
201
1629
1.28
2.57
3.6
4.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
272
0.40
2.53
1.4
2.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
33
3.05
2.53
1.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
392
0.50
2.50
1.6
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
379
4303
0.82
2.50
3.7
3.8
estimate
0.0
0.0
0.00
103
736
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
282
0.42
2.46
1.3
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
223
0.40
2.44
1.6
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
249
0.40
2.36
4.0
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
381
4305
0.83
2.35
4.8
5.1
estimate
0.0
0.0
0.00
102
730
(40768443) Skin Pathology biopsy report
16
330
0.48
2.34
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
153
1212
1.30
2.33
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
169
0.35
2.29
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
113
1.97
2.26
1.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
62
0.00
2.22
0.0
1.1
—
12.8
—
0
11
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
188
2264
0.80
2.15
1.6
1.7
pmol/l
478.7
16302397.6
1.50
154
1828
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
279
0.46
2.14
3.5
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
636
5877
1.18
2.13
4.6
4.7
e6/l
10.8
3144.2
—
8
94
(3009261) Glucose [Presence] in Urine by Test strip
389
4356
0.84
2.12
3.7
3.8
estimate
0.0
0.0
0.50
97
716
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
186
1537
1.25
2.03
3.2
2.6
e6/l
1.2
1.2
0.01
105
883
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
63
2.24
2.01
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
63
2.24
2.01
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
63
2.24
2.01
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
193
1.68
2.01
1.2
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
80
590
1.38
1.99
2.5
3.8
%
0.6
0.6
0.05
46
107
(1616796) Gas panel - Central venous blood
31
186
1.68
1.99
2.2
3.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
71
2.13
1.92
1.3
3.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
52
2.32
1.88
1.3
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
71
523
1.38
1.80
1.6
2.1
g/l
9.9
11.0
1.81
55
478
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
118
939
1.29
1.78
1.9
2.8
u/l
258.9
239.9
0.57
111
874
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
80
1044
0.75
1.73
2.2
2.6
ug/l
2.1
7.4
20.61
72
900
(3019832) Treponema pallidum Ab [Presence] in Serum
12
243
0.49
1.73
1.5
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
28
171
1.65
1.71
1.7
2.1
%
67.8
63.2
0.58
28
171
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
47
0.00
1.70
0.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
17
89
1.92
1.70
7.9
3.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
181
2136
0.82
1.70
1.8
1.8
nmol/l
1352.3
1176.9
1.68
150
1582
(3013512) EKG study
253
2893
0.84
1.69
3.9
4.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
49
0.00
1.68
0.0
1.3
—
71.8
—
0
13
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
65
482
1.37
1.61
4.4
3.2
%
52.2
47.7
0.82
65
472
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
26
2.70
1.58
1.4
2.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
50
357
1.42
1.55
1.1
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
449
4112
1.15
1.53
3.9
5.3
e9/l
0.6
0.6
0.99
370
3479
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
51
2.17
1.51
1.4
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
21
2.87
1.50
1.2
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
21
2.87
1.50
1.7
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
457
4196
1.15
1.49
4.0
5.4
e9/l
1.5
1.8
13.12
392
3621
(3052851) Hemolysis interference index of Serum or Plasma
39
268
1.47
1.48
6.0
4.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
79
614
1.31
1.45
2.5
3.9
%
0.1
0.1
0.88
54
127
(4034850)
21
340
0.61
1.45
19.9
11.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
450
4136
1.14
1.44
3.9
5.3
e9/l
0.0
0.0
1.19
373
3506
(3042631) Mycobacterium sp identified in Specimen
19
110
1.74
1.43
1.9
2.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
155
0.45
1.43
1.1
1.3
—
44.2
—
0
18
(36660697) Celiac disease serology panel - Serum
43
596
0.71
1.40
1.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
181
0.49
1.39
1.0
1.3
—
572.0
—
0
5
(3001019) Free T4 and TSH panel - Serum or Plasma
10
197
0.50
1.37
1.7
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
82
1.84
1.36
1.9
2.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
42
2.15
1.34
1.2
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
65
838
0.76
1.33
1.5
2.0
ug/g
154.6
162.8
0.04
53
646
(3036670) Protein [Mass/volume] in Synovial fluid
0
40
0.00
1.32
0.0
1.3
—
36.9
—
0
21
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
40
0.00
1.32
0.0
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
220
0.54
1.32
1.7
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
98
1.75
1.31
1.1
1.2
u/ml
243.3
255.2
—
10
58
(3026008) Bacteria identified in Urine by Culture
318
2872
1.15
1.30
3.0
3.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
62
800
0.76
1.29
1.1
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
304
0.62
1.27
1.4
2.5
g/l
0.5
0.3
—
8
99
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
55
2.01
1.27
1.0
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
32
220
1.47
1.24
4.6
2.8
mmol/l
9.9
7.8
2.15
32
213
(3032057) Clostridioides difficile [Presence] in Stool
6
25
2.41
1.24
2.0
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
74
585
1.28
1.23
2.6
4.0
%
0.0
0.8
0.49
48
115
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
19
2.64
1.21
1.0
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
42
306
1.39
1.21
2.3
3.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
68
858
0.78
1.20
4.2
3.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
139
1624
0.84
1.20
1.2
1.2
u/ml
4.4
1.6
0.37
34
421
(3037756) Immunofixation for Serum or Plasma
10
186
0.53
1.17
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
94
1.71
1.17
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
321
0.65
1.17
1.1
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
33
0.00
1.16
0.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
20
2.51
1.15
1.2
4.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
36
0.00
1.14
0.0
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
33
234
1.42
1.12
4.5
2.7
mmol/l
1.9
1.7
0.33
33
227
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
138
0.50
1.10
1.3
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
21
2.39
1.09
1.0
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
458
4274
1.12
1.09
4.1
5.5
e9/l
0.2
0.2
3.99
390
3680
(40768800) Prostate Pathology biopsy report
12
66
1.83
1.09
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
77
623
1.25
1.09
2.1
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
163
0.55
1.09
1.6
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
279
0.64
1.08
2.7
2.3
ug/min
93.9
106.9
0.09
12
170
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
98
1.64
1.03
1.4
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
106
1.61
1.03
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
248
1.38
1.00
1.2
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
135
0.52
0.98
2.7
3.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
61
1.81
0.98
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
30
215
1.41
0.98
2.7
2.6
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.1
—
20.8
—
0
6
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
100
1.61
0.97
1.4
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
31
0.00
0.96
0.0
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.1
—
213.5
—
0
31
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
32
0.00
0.95
0.0
1.1
—
63.3
—
0
7
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
32
0.00
0.95
0.0
1.1
—
1.1
—
0
13
(3003129) Base excess in Capillary blood by calculation
0
32
0.00
0.95
0.0
1.4
—
0.2
—
0
32
(42529406) Shigella sp [Presence] in Stool by Culture
34
251
1.37
0.94
1.2
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
37
1.90
0.94
1.3
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
320
3461
0.90
0.93
2.2
2.7
ug/l
284.0
144.4
6.71
297
3115
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
134
1.50
0.92
1.2
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
21
302
0.69
0.91
1.3
1.7
—
148.0
—
0
15
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
15
230
0.65
0.89
1.1
1.3
—
25.6
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
128
0.54
0.88
1.0
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
120
1378
0.86
0.87
1.3
1.3
g/l
2.6
2.8
0.80
72
767
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
103
1.56
0.87
1.4
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
103
1.56
0.87
1.4
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
103
1.56
0.87
1.4
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
168
0.59
0.87
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
247
1.35
0.86
1.2
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
49
389
1.27
0.85
1.8
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
80
1.63
0.84
1.3
1.9
%
12.5
10.7
0.90
13
80
(3022621) pH of Urine by Test strip
51
631
0.80
0.82
2.7
3.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
47
1.71
0.80
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
1695.1
—
0
24
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.5
—
0.4
—
0
12
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
187
0.64
0.78
1.5
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
26
0.00
0.78
0.0
1.2
—
115.7
—
0
21
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.3
—
160.6
—
0
20
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.1
—
0.3
—
0
18
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
35
269
1.31
0.78
4.7
4.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
97
0.51
0.78
1.2
1.3
—
76.1
—
0
6
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
82
1.59
0.78
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
99
1.52
0.75
1.4
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
53
1.70
0.75
1.4
1.6
umol/l
12.2
15.0
—
9
48
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
325
1.27
0.74
1.6
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
26
1.93
0.70
1.4
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
27
1.86
0.68
1.2
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
27
1.86
0.68
1.2
2.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
69
1.60
0.68
1.0
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
92
0.54
0.67
1.2
1.2
mmol/l
8.8
7.6
—
5
61
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
214
1968
1.11
0.67
3.4
4.2
ng/l
71.2
473.1
6.88
172
1679
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
94
1.50
0.67
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
62
1.62
0.65
5.4
2.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
1.4
1.2
nmol/l
0.1
0.2
—
5
22
(3007853) Bacteria identified in Skin by Aerobe culture
113
1008
1.13
0.60
1.6
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
160
1749
0.90
0.58
1.6
1.6
mg/l
3.5
1.3
2.80
143
1354
(3048879) Bone marrow aspiration report
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
23
0.00
0.58
0.0
2.3
—
2.8
—
0
7
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
89
0.56
0.56
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
186
1.30
0.54
1.1
1.7
—
—
—
0
0
(44806420)
6
38
1.58
0.54
2.2
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
38
457
0.83
0.52
1.6
3.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
43
362
1.20
0.50
1.8
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
108
0.65
0.48
3.0
4.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
594
6119
0.94
0.48
3.8
4.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
314
3302
0.93
0.48
4.0
4.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
76
1.45
0.48
1.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
352
3685
0.94
0.47
21.2
8.8
e9/l
0.0
0.0
1.35
273
2978
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
222
0.76
0.47
3.5
3.5
mg/l
46.7
27.3
0.75
12
151
(3041096) Erythrocytes [Presence] in Urine by Automated
231
2171
1.08
0.47
3.3
3.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
49
1.43
0.46
1.3
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
81
0.62
0.46
1.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
81
0.62
0.46
1.2
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
45
524
0.85
0.45
4.6
3.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
79
882
0.89
0.45
1.9
2.2
e9/l
73.5
68.9
0.33
61
692
(3026389) Candida sp identified in Specimen by Organism specific culture
6
94
0.64
0.42
1.5
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.3
—
6.4
—
0
8
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
95.1
—
0
15
(40765096) Chromosome analysis panel by Banding
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
39.7
—
0
6
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(4133840)
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
36
1.39
0.38
1.0
1.3
u/l
159.4
202.7
—
5
36
(3017732) Neutrophils [#/volume] in Blood
48
546
0.87
0.38
5.1
3.2
e9/l
3.8
4.2
0.41
40
385
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
158
0.76
0.37
1.1
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
5
37
1.35
0.37
1.8
2.1
—
42.3
—
0
16
(3023420) DNA double strand Ab [Units/volume] in Serum
5
78
0.64
0.35
1.2
1.4
—
32.6
—
0
5
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
126
1.27
0.35
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
377
3902
0.95
0.34
3.6
4.1
ng/l
42.9
70.1
0.70
308
2938
(3021901) Oxygen saturation in Capillary blood
14
177
0.79
0.33
2.1
2.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
126
1180
1.08
0.31
1.6
2.1
%
2.1
1.8
1.43
119
1020
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
152
0.79
0.29
1.1
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
80
737
1.09
0.29
1.3
1.7
%
1.7
1.6
0.39
58
610
(3013139) Helicobacter pylori Ag [Presence] in Stool
50
554
0.90
0.28
1.2
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
53
584
0.90
0.27
1.7
3.4
mmol/l
2.4
1.9
0.29
34
430
(46235355) HIV 1 and 2 tests - Meaningful Use set
77
712
1.09
0.27
1.6
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
72
0.69
0.26
5.8
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
138
0.80
0.25
2.2
2.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
81
0.74
0.24
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
84
0.71
0.24
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
84
0.71
0.24
1.2
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
85
0.70
0.24
1.0
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
252
2435
1.04
0.23
2.0
2.2
mg/l
3.1
3.0
0.28
228
2037
(3028026) IgM [Mass/volume] in Serum or Plasma
46
418
1.10
0.23
1.3
1.3
g/l
1.0
1.2
0.80
41
380
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
69
741
0.93
0.22
1.8
1.7
nmol/l
423.8
358.8
1.45
64
662
(4146454)
11
135
0.81
0.22
2.2
2.7
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
14.6
—
0
12
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
30
335
0.89
0.21
3.1
1.9
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
14
0.00
0.20
0.0
2.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
90
952
0.94
0.20
2.8
3.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
58
620
0.93
0.18
1.7
3.5
kpa
4.9
5.2
2.12
50
569
(3035637) Corticotropin [Mass/volume] in Plasma
7
60
1.17
0.18
1.0
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
216
0.88
0.17
1.7
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
57
608
0.93
0.17
1.7
3.5
ph
7.5
7.4
—
7
69
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
130
1.16
0.15
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
6
79
0.76
0.15
1.2
1.2
iu/l
46.5
27.5
—
6
70
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
86
0.81
0.14
4.4
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
105
1010
1.04
0.14
2.5
3.2
ng/l
240.9
235.5
0.04
97
944
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
170
0.88
0.13
1.2
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
242
2369
1.03
0.12
3.8
4.1
estimate
0.0
0.0
0.50
90
701
(3000494) Fungus identified in Specimen by Culture
102
986
1.04
0.11
1.8
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
23
211
1.09
0.11
1.7
2.9
kpa
7.8
7.8
0.02
18
192
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
114
0.88
0.09
1.4
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
62
0.81
0.08
1.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
64
1.09
0.08
1.4
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
71
0.84
0.07
1.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
108
1.11
0.07
1.0
1.2
nmol/l
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
83
0.84
0.07
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
132
0.91
0.06
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
52
536
0.97
0.05
2.5
2.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
13
120
1.08
0.05
3.8
8.0
mmol/l
8.3
7.6
0.30
13
100
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
72
736
0.98
0.04
4.7
2.4
ml/min/173m2
62.9
63.2
0.02
28
295
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
221
0.95
0.04
2.0
2.1
g/l
114.3
133.2
1.98
15
165
(3000034) Microalbumin [Mass/volume] in Urine
10
91
1.10
0.04
2.0
3.1
mg/l
7.5
14.7
—
5
72
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
109
0.92
0.04
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
32
329
0.97
0.02
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
278
0.97
0.02
1.8
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
151
1501
1.01
0.01
15.8
29.6
inr
1.3
1.4
0.36
26
206
(3015235) Bicarbonate [Moles/volume] in Capillary blood
26
254
1.02
0.00
1.7
3.3
mmol/l
24.4
25.3
0.28
20
222
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
222
0.99
0.00
1.4
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
445
1.01
0.00
1.2
1.6
g/l
1.7
1.5
0.44
37
380
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
115
0.96
0.00
1.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
18.1
—
0
8
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
65
0.92
0.00
1.2
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
17.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
312.6
—
0
5
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
54
0.93
0.00
1.0
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
60
1.00
0.00
2.7
2.9
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
64
0.94
0.00
1.2
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
53
0.94
0.00
2.2
2.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_PANCREAS_ADENO_DUCTAL_EXALLC – Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).